CTSOVSSLXN• 6 Months (Normalized)
CTSO vs SLXN (Cytosorbents Corporation vs Silexion Therapeutics Corp)
Showing Closing Date Range from Apr 1 to Sep 28, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CTSO Performance $4.91
+797.62%
Cytosorbents Corporation
Normalized Baseline0.00%
SLXN Performance $0.32
-97.42%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin CTSO LEADS
+895.04 pts
CTSO outperforming by 895.04 percentage points
CTSOSLXN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CTSO SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(121 dates)
| Date | CTSO Price | CTSO Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 23, 2026 | $4.91 | +797.62% | $0.32 | -97.42% | +895.04% |
| Sep 22, 2026 | $- | $0.39 | -96.79% | - | |
| Sep 21, 2026 | $5.51 | +907.31% | $0.54 | -95.54% | +1002.85% |
| Sep 18, 2026 | $5.75 | +951.19% | $0.44 | -96.43% | +1047.62% |
| Sep 17, 2026 | $5.76 | +953.02% | $0.38 | -96.89% | +1049.91% |
| Sep 16, 2026 | $5.73 | +947.53% | $0.34 | -97.21% | +1044.74% |
| Sep 15, 2026 | $6.06 | +1007.86% | $0.34 | -97.21% | +1105.07% |
| Sep 14, 2026 | $6.07 | +1009.69% | $0.39 | -96.84% | +1106.53% |
| Sep 11, 2026 | $6.41 | +1071.85% | $0.36 | -97.07% | +1168.92% |
| Sep 10, 2026 | $6.37 | +1064.53% | $0.42 | -96.53% | +1161.06% |
| Sep 09, 2026 | $6.33 | +1057.22% | $0.35 | -97.13% | +1154.35% |
| Sep 08, 2026 | $- | $0.35 | -97.17% | - | |
| Sep 04, 2026 | $0.35 | -36.01% | $0.35 | -97.11% | +61.10% |
| Sep 03, 2026 | $0.35 | -36.01% | $0.35 | -97.11% | +61.10% |
| Sep 02, 2026 | $0.38 | -29.80% | $0.35 | -97.12% | +67.32% |
Page 1 of 9